Prostate Cancer - Results from #600

Prostate Cancer Awareness in the Middle East: A Cross-Sectional International Study. July 23, 2024

Targeting androgen receptor degradation with PROTACs from bench to bedside. July 22, 2024

Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer. July 22, 2024

Comparison of synthesized and acquired high b-value diffusion-weighted MRI for detection of prostate cancer. July 22, 2024

61Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging. July 22, 2024

Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer. July 22, 2024

PSA, an outdated biomarker for prostate cancer: in search of a more specific biomarker, citrate takes the spotlight. July 22, 2024

Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer. July 22, 2024

Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized ControlledTrial. July 22, 2024

Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry. July 22, 2024

The 30th Annual Prostate Cancer Foundation Scientific Retreat Report. July 19, 2024

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer. July 19, 2024

PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer. July 19, 2024

Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer. July 19, 2024

Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement. July 19, 2024

Target Volume Optimization for Localized Prostate Cancer. July 19, 2024

PROTAC'ing the androgen receptor and other emerging therapeutics in prostate cancer. July 19, 2024

Effects of high-intensity interval training on cardiometabolic biomarkers in patients with prostate cancer undergoing active surveillance: a randomized controlled trial. July 19, 2024

An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer. July 19, 2024

A Systematic Review of Family History, Race/Ethnicity, and Genetic Risk on Prostate Cancer Detection and Outcomes: Considerations in PSA-based Screening. July 19, 2024

Page 31 of 1438